Prenatal testing is a critical aspect of maternal-fetal healthcare, aiming to assess the health and development of the fetus during pregnancy. The scope of the prenatal testing market is extensive and continually evolving, reflecting the dynamic landscape of technologies, and methodologies employed to assess fetal health during the pregnancy.
The prenatal testing market has experienced significant growth, fueled by advancements in medical technology and increasing awareness among expectant parents. Noninvasive prenatal testing (NIPT) has emerged as a prominent trend, offering a safer alternative to traditional invasive procedures for assessing fetal genetic abnormalities.
According to our BCC Research, the global market for prenatal testing was valued at $10.9 billion in 2023, and it is forecast to grow at a CAGR of 12.6% to reach a value of $19.8 billion through 2028.